iRhythm

iRhythm is a health technology company that focuses on wearable cardiac monitoring solutions designed to detect and analyze heart rhythm abnormalities. Its primary product line includes adhesive patch monitors that patients wear for extended periods to capture electrocardiographic data, which is then processed and reported to healthcare providers for clinical decision‑making. The company serves a broad market that encompasses cardiology practices, primary care physicians, hospital systems, and patients who require ambulatory arrhythmia detection beyond traditional Holter monitoring. iRhythm’s services are intended to support timely diagnosis of conditions such as atrial fibrillation, bradycardia, tachycardia, and other symptomatic or asymptomatic arrhythmias that may otherwise go undetected during intermittent testing. The firm emphasizes ease of use, patient comfort, and high‑fidelity signal acquisition as core aspects of its monitoring platform.

Distinguishing attributes of iRhythm include its specialization in medically regulated wearable devices that have received clearance from the U.S. Food and Drug Administration, positioning it as a regulated medical device manufacturer within the digital health sector. The company’s competency lies in integrating biosensor technology, data analytics algorithms, and cloud‑based reporting tools to deliver actionable cardiac insights while maintaining compliance with healthcare privacy standards such as HIPAA. Although the prompt does not provide explicit details about the organization’s size, revenue, employee count, or ownership structure, it notes that iRhythm does not store individual financial account or payment card information and that its clinical, medical device, manufacturing, distribution, patient safety, and financial reporting systems remained unaffected during the disclosed cyber incident. The firm relies on third‑party‑hosted business applications for certain operational functions, which were the vector of the 2026 cyberattack involving social engineering and alleged data exfiltration. External cybersecurity experts were engaged to investigate the scope and impact of that breach, though the outcome regarding ransom payment or responsible threat actor remains unspecified in the available information.